Adam Crystal, See Remarks at Tango Therapeutics, Inc. (TNGX), sold 16,742 shares at $12.56 ($211K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Open-market sale of $211k TNGX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.56 | 4,288 | $54K | 25.6% |
| 2 | $12.56 | 4,288 | $54K | 25.6% |
| 3 | $12.62 | 4,083 | $52K | 24.4% |
| 4 | $12.62 | 4,083 | $52K | 24.4% |
| Total | $12.59 avg | 16,742 | $211K | 100% |
| Filing → |
| TNGX | SELL | 2026-08-05 | $736K | — | Filing → |
| TNGX | SELL | 2026-07-02 | $799K | — | Filing → |
| TNGX | SELL | 2026-06-03 | $618K | — | Filing → |